Celon Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	287	333	182	153	369	399
Market Cap Growth	-6.29%	83.28%	18.79%	-58.52%	-7.70%	-4.96%
Enterprise Value	285	312	162	123	324	396
Last Close Price	5.14	5.87	3.46	2.94	6.69	-
PS Ratio	5.43	6.93	3.68	3.69	8.62	11.59
PB Ratio	3.15	3.20	1.77	1.49	3.05	5.30
P/TBV Ratio	3.17	3.26	1.83	1.56	3.21	5.96
P/FCF Ratio	-	-	-	-	650.25	-
P/OCF Ratio	2588.08	-	-	-	38.47	25.44
EV/Sales Ratio	5.34	6.50	3.28	2.98	7.59	11.48
EV/EBITDA Ratio	-	-	81.54	-	53.42	70.90
EV/FCF Ratio	-29.52	-	-	-	572.04	-
Debt / Equity Ratio	0.04	0.04	0.06	0.06	0.03	0.07
Debt / EBITDA Ratio	-	-	1.24	5.92	0.52	1.00
Debt / FCF Ratio	-	-	-	-	5.74	-
Net Debt / Equity Ratio	-0.02	-0.13	-0.20	-0.29	-0.38	-0.05
Net Debt / EBITDA Ratio	0.08	3.88	-10.30	53.60	-7.64	-0.73
Net Debt / FCF Ratio	0.17	1.70	2.16	3.57	-81.78	0.67
Asset Turnover	0.41	0.37	0.35	0.29	0.32	0.28
Inventory Turnover	2.82	2.23	2.06	2.15	2.32	1.23
Quick Ratio	1.38	1.90	1.89	1.70	2.95	0.75
Current Ratio	1.90	2.40	2.20	2.04	3.23	1.05
Return on Equity (ROE)	-27.03%	-7.73%	-6.08%	-7.60%	-2.58%	-0.23%
Return on Assets (ROA)	-12.83%	-5.94%	-2.92%	-3.51%	-1.07%	-0.46%
Return on Invested Capital (ROIC)	-29.93%	-14.24%	-8.12%	-11.09%	-3.17%	-1.16%
Return on Capital Employed (ROCE)	-26.90%	-11.10%	-5.90%	-7.20%	-1.70%	-1.00%
Earnings Yield	-10.00%	-2.42%	-3.56%	-5.49%	-0.69%	-0.05%
FCF Yield	-3.37%	-2.40%	-5.21%	-5.40%	0.15%	-1.52%
Dividend Yield	-	-	0.53%	0.66%	0.95%	-
Buyback Yield / Dilution	1.95%	-2.86%	-0.04%	-9.32%	-3.74%	-
Total Shareholder Return	1.95%	-2.86%	0.49%	-8.66%	-2.80%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.